HIV in Pregnancy--Prevalence and Access to Care
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In one developing Asian country, not a single case of HIV was found among several thousand pregnant women tested. Yet in one African country, a whopping 40% of pregnant women were infected. How can either be true? Why? Today our guest is Dr. Susan Cu-Uvin, professor of obstetrics and gynecology and Medicine at Brown Medical School. She is also Director of the Miriam Hospital's Immunology Center in Providence Rhode Island, which provides comprehensive care to over a thousand women and men living with HIV/AIDS. She is doing NIH funded research on the prevalence and transmission of HIV among during pregnancy.
Overview
In one developing Asian country, not a single case of HIV was found among several thousand pregnant women tested. Yet in one African country, a whopping 40% of pregnant women were infected. How can either be true? Why? Today our guest is Dr. Susan Cu-Uvin, professor of obstetrics and gynecology and Medicine at Brown Medical School. She is also Director of the Miriam Hospital's Immunology Center in Providence Rhode Island, which provides comprehensive care to over a thousand women and men living with HIV/AIDS. She is doing NIH funded research on the prevalence and transmission of HIV among during pregnancy.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?